$1 billion? After taking Pfizer COVID-19 specific medicine for 5 days, the director of the US CDC successfully became positive. Since the outbreak of the COVID-19 in 2020, this catastrophe of all mankind has not ended. The United States did not take active response measures after the outbreak of the epidemic, which led to the number of confirmed cases in the United States maintaining a high status for a long time.
Lorenski, director of the US Centers for Disease Control and Prevention, was infected with COVID-19 and took COVID-19 specific drugs manufactured by Pfizer in the course of treatment. However, his nucleic acid test results turned negative and then showed positive. The effect of Pfizer specific drug is not as good as everyone imagined.
Director of CDC takes Pfizer COVID-19 specific drug Fuyang
After the outbreak of the epidemic, Pfizer made a lot of investment in vaccines and medical research, and successfully launched the COVID-19 specific drug Paxlovid. Pfizer and the US government are very confident about the effect of this drug.
The director of the US Centers for Disease Control and Prevention, Valensky, was infected with COVID-19 some time ago. During the treatment, he took Pfizer's COVID-19 specific drug for five consecutive days, and finally his nucleic acid test result was negative. But two days later, Vorenski's nucleic acid test showed positive again. In other words, Pfizer's new drug did not completely cure Wolenski's viral infection.
In fact, this has happened more than once, as has Fauci, the White House's chief medical adviser. At present, a total of three officials in the White House have recovered after taking the drug. Many netizens believe that the United States' anti epidemic drug can not compete with COVID-19.
$1 billion
Pfizer is an American company. In order to prove the value and effectiveness of Pfizer COVID-19 specific drug, the U.S. government has invested 1 billion dollars to purchase the drug. However, judging from the current situation, the US's 1 billion yuan may have been lost. Some medical experts said that the recovery of positive after taking Pfizer COVID-19 treatment drug is common among the confirmed COVID-19 group in the United States.
The American media published an article saying that the main effect of this drug is to reduce the mortality and severity rate of the elderly after infection. In other words, the effect of this drug is very limited for young people. This means that the market of this drug itself has great limitations, and it cannot play a significant role in the process of anti epidemic.
At present, the number of deaths caused by COVID-19 in the United States has exceeded 1 million. Of all the developed countries, the United States had the worst outcome. The reason for this is that the U.S. government did not take effective measures to prevent the spread of the epidemic after the outbreak of the epidemic, and the American people have great doubts about vaccination, leading to its vaccination rate being far lower than that of other countries.
The medical level and medical resources of the United States are world leading. In this case, a large number of people will die because of the virus, which proves that the current epidemic prevention policy of the United States has a big problem.
The medical staff in the United States has been operating at full capacity for a long time. The Biden government must find ways to solve these problems to provide the necessary guarantee for the life safety of the American people.